CtrlK
Intensity Therapeutics, Inc. - Common Stock
INTS35
$2.32arrow_drop_down0.63%-$0.01
NASDAQ - As of Mar 14, 6:08 AM EDT Market Closed
Penny Stock
INTS35
$2.32
arrow_drop_down0.63%Performance History
arrow_drop_down51.66%
(-$2.48 )
| Key Stats | |
|---|---|
| Open | $2.38 |
| Prev. Close | $2.33 |
| EPS | -1.07 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $35.11M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 2.18 | 2.33 |
| 52 Week Range | 1.58 | 11.44 |
| Ratios | |
|---|---|
| P/B Ratio | 12.77 |
| Revenue | - |
| Operating M. % | 0.00% |
| Earnings | $0.00 |
| Earnings Growth % | -38.99% |
| EBITDA Margin % | - |
| ROE % | -173.99% |
| EPS | -1.07 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Predicted: just now
info
Analyzed by 5 Wall Street experts, Intensity Therapeutics, Inc. - Common Stock's 12-month projections average at $12.00, spanning from a high of $12.00 to a low of $12.00. This signifies an 416.12% shift from the current price of $2.32.
Analyst Ratings
Buy
| Buy | 4 | 100.00% | |
|---|---|---|---|
| Hold | 0 | 0.00% | |
| Sell | 0 | 0.00% |
•Ratings from: March•
Last updated: just now
•Total: 4info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.
Correlated Companies
About Intensity Therapeutics, Inc. - Common Stock (INTS)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Lewis H. Bender M.A., M.B.A., M.S.
- Headquarters
- Westport
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on Intensity Therapeutics, Inc. - Common Stock
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Intensity Therapeutics, Inc. - Common Stock's (INTS) price per share?
The current price per share for Intensity Therapeutics, Inc. - Common Stock (INTS) is $2.33. The stock has seen a price change of -$0.01 recently, indicating a -0.64% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Intensity Therapeutics, Inc. - Common Stock (INTS)?
For Intensity Therapeutics, Inc. - Common Stock (INTS), the 52-week high is $11.44, which is 392.04% from the current price. The 52-week low is $1.58, the current price is 47.15% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Intensity Therapeutics, Inc. - Common Stock (INTS) a growth stock?
Intensity Therapeutics, Inc. - Common Stock (INTS) has shown an average price growth of -1.65% over the past three years. It has received a score of 4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Intensity Therapeutics, Inc. - Common Stock as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Intensity Therapeutics, Inc. - Common Stock (INTS) stock price performance year to date (YTD)?
As of the latest data, Intensity Therapeutics, Inc. - Common Stock (INTS) has a year-to-date price change of 32.1%. Over the past month, the stock has experienced a price change of 7.14%. Over the last three months, the change has been 12.86%. Over the past six months, the figure is -44.77%.
help
Is Intensity Therapeutics, Inc. - Common Stock (INTS) a profitable company?
Intensity Therapeutics, Inc. - Common Stock (INTS) has a net income of -$10.54M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.32M. Furthermore, the EBITDA is $0.
help
What is the market capitalization of Intensity Therapeutics, Inc. - Common Stock (INTS)?
Intensity Therapeutics, Inc. - Common Stock (INTS) has a market capitalization of $35.12M. The average daily trading volume is 2.29, indicating the stock's liquidity and investor engagement.